ClinicalTrials.gov
ClinicalTrials.gov Menu

Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00872872
Recruitment Status : Active, not recruiting
First Posted : March 31, 2009
Last Update Posted : May 9, 2017
Sponsor:
Collaborators:
Chulalongkorn University
Queen Savang Vadhana Memorial Hospital, Thailand
Information provided by (Responsible Party):
Thai Red Cross AIDS Research Centre

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : April 2019
  Estimated Study Completion Date : April 2025